- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Depression & Anxiety in Cystic Fibrosis: Annual Screening Required
Depression in people with cystic fibrosis is 2 times higher than in the general population and among their caretakers, 3 times higher. The toll on treatment adherence is significant.
Clincians who care for children, teens and adults with cystic fibrosis (CF) should annually screen for depression and anxiety in these patients, as well as in their parents/caretakers. This was the conclusion of a landmark study on the prevalence of mental health challenges in the CF population first published in the journal Thorax in December 2014.The study, led by Alexandra Quittner, PhD, senior scientist, Miami Children's Research Institute, formed the basis for guidelines released by the Cystic Fibrosis Foundation and European Cystic Fibrosis Society in 2015, which recommend annual screening and treatment for depression and anxiety in teens and adults with CF, as well as their caretakers.The short slide show below highlights the pivotal research and links to a quiz on best practices outline in the guidelines.
